KCAS Bio will be participating in Nordic Life Science Days (NLSDays) 2025, taking place October 13-14 in Gothenburg, Sweden.
The conference focuses on early-stage drug development, partnerships, and innovation within the life sciences sector. Hosted by SwedenBIO, NLSDays brings together top scientists and business developers from across Europe to explore scientific and strategic developments in biologics, therapeutics, and related technologies. By convening stakeholders from across the industry, the event encourages cross-border dialogue around collaboration and the integration of new technologies.
View the program agenda here.
Looking Forward in Life Sciences at KCAS Bio
KCAS Bio’s core expertise spans biologics, cell and gene therapies, and immunogenicity assessment. Our scientists develop and validate robust, regulatory-aligned assays to characterize drug activity, detect anti-drug antibodies, and evaluate immune responses across preclinical and clinical stages. With a focus on scientific rigor and flexibility, we help biopharma partners generate the high-quality data needed to advance complex therapeutic candidates.
KCAS Bio maintains a forward-looking approach and stays at the forefront of scientific advancements that shape the future of drug development. Through continuous investment in emerging technologies, method innovation, and regulatory insight, we actively monitor and adapt to the evolving landscape of biologics, cell and gene therapies, and immunogenicity science.
Global Engagement
Participating in NLSDays 2025 reflects KCAS Bio’s ongoing commitment to engaging in and contributing to the global dialogue around modern drug development. As the landscape of advanced biologics continues to evolve, we find it essential to be part of the conversations shaping the future of translational research and clinical advancement. Global engagement allows us to better understand regional needs and support partners across diverse markets. We are proud to be exhibiting at NLSDays to share our scientific capabilities and learn from others.
Let’s Connect
Connect with our team, Charisse Fernandez, and Mouhssin Oufir, Ph.D., at NLSDays 2025 to explore how KCAS Bio can help with your project goals. In any stage of drug development, KCAS Bio is here provide unique specialized support. Charisse and Mouhssin are prepared to answer questions on any aspect of life sciences and drug development throughout the conference.